Special Interest Session II: International Session

Special Interest Session


  • Teresa P. Diaz-Montes, MD, Mercy Medical Center, Baltimore, MD
  • Min Kyu Kim, MD, Sung Kyun Kwan University of Medicine, Changwon-Si, South Korea
  • Stefanie Ueda, MD, University of California San Francisco, San Francisco, CA


  • Agnes Binagwaho, MD, M(Ped), PhD, University of Global Health Equity, Kigali, Rwanda
  • Linus Chuang, MD, Icahn School of Medicine at Mount Sinai, New York, NY
  • Edward Trimble, MD, MPH, National Cancer Institute, NIH, DHHS, Rockville, MD

International Clinical Trials:

  • Marie Plante, MD, Laval University, L’Hotel-Dieu de Quebec, Quebec City, Canada
  • K. Fujiwara, MD, Saitama Medical University, International Medical Center, Hidaka, Japan
  • J. Berek, MD, Stanford Cancer Insititute, Stanford University School of Medicine, Stanford, CA

Description: This session explores the global burden of gynecologic cancer and evaluates strategies to improve gynecologic cancer care including the role of international clinical trials.

Location: Kalakaua B

Harnessing artificial intelligence and digital diffraction to advance point-of-care HPV 16 and 18 detection
C.M. Castro1, H. Im1, H. Lee1, M. Avila-Wallace2, R. Weissleder1 and T. Randall1
1Massachusetts General Hospital, Boston, MA, USA, 2Gillette Center for Gynecologic Oncology/Massachusetts General Hospital, Boston, MA, USA

Accuracy of high-risk HPV DNA detection from urine and cervical samples in abnormal Pap smear women
V. Achariyapota1 and A. Punyashthira2
1Faculty of Medicine Siriraj Hospital, Bangkok, Thailand, 2Thammasat University, Pathum Thani, Thailand

Abstract has been withdrawn at author’s request.

Phase II randomized, double-blind, placebo-controlled evaluation of AHCC for the eradication of HPV infections in women with HPV positive Pap smears
J.A. Smith1, A.A. Gaikwad1, B. Rech1, J. Faro2, J.A. Lucci III1, R. Olsen4 and T.T. Byrd1
1The University of Texas Medical School at Houston, Houston, TX, USA, 2Specialists in Obstetrics & Gynecology, Houston, TX, USA, 3Houston Methodist Hospital, Houston, TX, USA

The world ovarian cancer coalition every woman study: Identifying global and local challenges, and the opportunities to improve survival and quality of life for women no matter where they live
F. Reid and A. Jones
World Ovarian Cancer Coalition, London, United Kingdom

Long term consequences of cervical cancer treatment if we don’t get it right
R. Music
Jo’s Cervical Cancer Trust, London, United Kingdom

Concurrent chemoradiotherapy for adenocarcinoma of the uterine cervix: Japanese Gynecologic Oncology Group (JGOG) multicenter retrospective study
Y. Nagai1, M. Takekuma2, R. Kitagawa3, E. Kobayashi4, A. Tozawa5, S. Nagao6, S. Nishio7, T. Toita8, M. Mikami9 and T. Sugiyama10
1Okinawa Prefectural Nanbu Medical Center & Children’s Medical Center, Okinawa, Japan, 2Shizuoka Cancer Center, Shizuoka, Japan, 3Tohoku Medical and Pharmaceutical University, Miyagi, Japan, 4Osaka University, Osaka, Japan, 5St. Mariannna University School of Medicine, Kanagawa, Japan, 6Hyogo Cancer Center, Akashi, Hyogo, Japan, 7Kurume University School of Medicine, Fukoaka, Japan, 8Okinawa Prefectural Chubu Hospital, Okinawa, Japan, 9Tokai University School of Medicine, Isehara, Japan, 10Takagi Hospital, Fukuoka, Japan

Concurrent chemoradiotherapy for cervical cancer in a single institution: High-dose rate brachytherapy vs helical tomotherapy
S. Kim, K.J. Ryu, S. Lee and J.Y. Song
Korea University College of Medicine, Seoul, South Korea

Safety, acceptability and efficacy of a new thermal ablation technique to prevent cervical cancer in low- and middle-income countries – preliminary results
L.F. Pinder1,2, P. Basu3, W. Prendiville3, R. Muwonge3, E. Lucas3 and G.P. Parham2,4
1University of Washington Medical Center, Seattle, WA, USA, 2Women and Newborn Hospital, University Teaching Hospital, Lusaka, Zambia, 3International Agency for Research on Cancer, Lyon, France, 4University of North Carolina at Chapel Hill,
Chapel Hill, NC, USA

Lynch syndrome screening in Thai endometrial cancer patients
T. Manchana
Chulalongkorn University, Bangkok, Thailand

Risk of recurrence and HPV type-distribution among patients with vaginal intraepithelial neoplasia
S.C. Kim1 and M.K. Kim2
1Ewha Womans University Hospital, Seoul, South Korea, 2Ewha Womans University, Seoul, Korea, South Korea

Impact of metformin on survival outcome in ovarian cancer: A nationwide population-based cohort study
M.H. Baek1, Y.H. Park1 and H.B. Kim2
1Hallym University Sacred Heart Hospital, Anyang, South Korea, 2Hallym University Kangnam Sacred Heart Hospital, Seoul, South Korea